Published • loading... • Updated
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
- Eloxx Pharmaceuticals announced a public offering of 2,975,000 common stock shares at $11.00 each and pre-funded warrants for 3,025,000 shares at $10.99 each.
- All securities in this offering are being sold directly by Eloxx Pharmaceuticals, which expects to raise gross proceeds of $66.0 million before deducting fees and expenses.
- The company's common stock will begin trading on the Nasdaq Capital Market on June 9, 2026, under the ticker symbol 'ELOX'.
- The offering is planned to close on June 10, 2026, pending standard closing conditions.
Insights by Ground AI
31 Articles
31 Articles
The Conway Daily Sun+30 Reposted by 30 other sources
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
ARLINGTON, Mass., June 8, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) ("Eloxx" and the "Company"), a clinical-stage biopharmaceutical company developing novel, small molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources31
Leaning Left5Leaning Right6Center11Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 23%
C 50%
R 27%
Factuality
To view factuality data please Upgrade to Premium
